Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae
Ceftazidime-avibactam (CAZ-AVI) shows promising activity against carbapenem-resistant Klebsiella pneumoniae (CRKP), however, CAZ-AVI resistance have emerged recently. Mutations in KPCs, porins OmpK35 and/or OmpK36, and PBPs are known to contribute to the resistance to CAZ-AVI in CRKP. To identify novel CAZ-AVI resistance mechanism, we generated 10 CAZ-AVI-resistant strains from 14 CAZ-AVI susceptible KPC-producing K. pneumoniae (KPC-Kp) strains through in vitro multipassage resistance selection using low concentrations of CAZ-AVI. Comparative genomic analysis for the original and derived mutants identified CAZ-AVI resistance-associated mutations in KPCs, PBP3 (encoded by ftsI), and LamB, an outer membrane maltoporin. CAZ-AVI susceptible KPC-Kp strains became resistant when complemented with mutated blaKPC genes. Complementation experiments also showed that a plasmid borne copy of wild-type lamB or ftsI gene reduced the MIC value of CAZ-AVI in the induced resistant strains. In addition, blaKPC expression level increased in four of the six CAZ-AVI-resistant strains without KPC mutations, indicating a probable association between increased blaKPC expression and increased resistance in these strains. In conclusion, we here identified a novel mechanism of CAZ-AVI resistance associated with mutations in porin LamB in KPC-Kp..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Emerging Microbes and Infections - 10(2021), 1, Seite 2042-2051 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yingyi Guo [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Ceftazidime-avibactam |
---|
doi: |
10.1080/22221751.2021.1984182 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ017950449 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ017950449 | ||
003 | DE-627 | ||
005 | 20230503060629.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/22221751.2021.1984182 |2 doi | |
035 | |a (DE-627)DOAJ017950449 | ||
035 | |a (DE-599)DOAJb81a4a29f017452eb0621d75543751e5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC109-216 | |
050 | 0 | |a QR1-502 | |
100 | 0 | |a Yingyi Guo |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Ceftazidime-avibactam (CAZ-AVI) shows promising activity against carbapenem-resistant Klebsiella pneumoniae (CRKP), however, CAZ-AVI resistance have emerged recently. Mutations in KPCs, porins OmpK35 and/or OmpK36, and PBPs are known to contribute to the resistance to CAZ-AVI in CRKP. To identify novel CAZ-AVI resistance mechanism, we generated 10 CAZ-AVI-resistant strains from 14 CAZ-AVI susceptible KPC-producing K. pneumoniae (KPC-Kp) strains through in vitro multipassage resistance selection using low concentrations of CAZ-AVI. Comparative genomic analysis for the original and derived mutants identified CAZ-AVI resistance-associated mutations in KPCs, PBP3 (encoded by ftsI), and LamB, an outer membrane maltoporin. CAZ-AVI susceptible KPC-Kp strains became resistant when complemented with mutated blaKPC genes. Complementation experiments also showed that a plasmid borne copy of wild-type lamB or ftsI gene reduced the MIC value of CAZ-AVI in the induced resistant strains. In addition, blaKPC expression level increased in four of the six CAZ-AVI-resistant strains without KPC mutations, indicating a probable association between increased blaKPC expression and increased resistance in these strains. In conclusion, we here identified a novel mechanism of CAZ-AVI resistance associated with mutations in porin LamB in KPC-Kp. | ||
650 | 4 | |a Ceftazidime-avibactam | |
650 | 4 | |a KPC | |
650 | 4 | |a LamB | |
650 | 4 | |a PBP3 | |
650 | 4 | |a expression level of blaKPC | |
653 | 0 | |a Infectious and parasitic diseases | |
653 | 0 | |a Microbiology | |
700 | 0 | |a Ningjing Liu |e verfasserin |4 aut | |
700 | 0 | |a Zhiwei Lin |e verfasserin |4 aut | |
700 | 0 | |a Xiaoliang Ba |e verfasserin |4 aut | |
700 | 0 | |a Chuyue Zhuo |e verfasserin |4 aut | |
700 | 0 | |a Feifeng Li |e verfasserin |4 aut | |
700 | 0 | |a Jiong Wang |e verfasserin |4 aut | |
700 | 0 | |a Yitan Li |e verfasserin |4 aut | |
700 | 0 | |a Likang Yao |e verfasserin |4 aut | |
700 | 0 | |a Baomo Liu |e verfasserin |4 aut | |
700 | 0 | |a Shunian Xiao |e verfasserin |4 aut | |
700 | 0 | |a Ying Jiang |e verfasserin |4 aut | |
700 | 0 | |a Chao Zhuo |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Emerging Microbes and Infections |d Taylor & Francis Group, 2013 |g 10(2021), 1, Seite 2042-2051 |w (DE-627)DOAJ00011538X |x 22221751 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:1 |g pages:2042-2051 |
856 | 4 | 0 | |u https://doi.org/10.1080/22221751.2021.1984182 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/b81a4a29f017452eb0621d75543751e5 |z kostenfrei |
856 | 4 | 0 | |u https://www.tandfonline.com/doi/10.1080/22221751.2021.1984182 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2222-1751 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 1 |h 2042-2051 |